In 1998, I was diagnosed with metastatic melanoma and given months to live. I consulted more than a dozen leading oncologists and got conflicting recommendations. No one could tell me: ‘Which treatment is best for me?’

A clinical trial saved my life—despite itself being unsuccessful—only raising more questions. Why did this therapy work for me but not for others? Could my experience help similar patients? It was life-saving knowledge I wanted to share with all cancer patients.

Welcome to Cancer Commons.

Marty Tenenbaum, PhD Founder of Cancer Commons

Help for Advanced Cancer Patients: Learn More or

Get Started Now

Our Services

We provide patients and their care teams with the actionable information and data they need to make informed decisions. We help identify and access individualized regimen of therapies that specifically target the molecular drivers of their disease and refer patients to a myriad of precision oncology services to help them navigate the cancer maze and minimize trial and error.

Get Help

Always Learning

What makes Cancer Commons unique is our continuous learning health system.

As we help patients identify and access novel tests, treatments, and trials, we learn continuously from every patient's experience—and share that knowledge with the world.

Learn More

Support Us

We've been helping cancer patients for more than a decade—and our services are free, supported by generous donations/philanthropy.

Please help us continue our work serving patients and changing the field of oncology with tax-deductible donation in any amount, and learn about other ways to support our mission.

Support Us

Since our founding in 2011, we have delivered personalized, evidence-based guidance at no charge to more than 10,000 patients and caregivers, supported entirely by philanthropy.

Get Help

  • The team was a great complement to my local oncology team! The findings of the analysis and tumor board recommendations helped confirm that our “First line standard of care” was corroborated and also offered a potential map of 2nd and 3rd line care. Further, clinical trials pertinent to my specific genomic cancer were identified with the closest providers currently offering trial enrollment.

    Mary Lou
    Metastatic colorectal cancer patient

  • You’re not alone. Cancer Commons is a great resource and sounding board to ask questions and get advice and support.

    Karen
    Advanced breast cancer patient

  • The team at Cancer Commons provided options above and beyond what the local care team had offered. Such a great service for patients.

    Anonymous

  • Whenever we needed them they were there. Whenever we needed new information or help finding a new treatment they were there immediately. They were such a pleasure to deal with that they were like a family member helping you out, and believe me I/we needed them. 

    Dr. Mel Burchman
    Spouse of a pancreatic cancer patient

  • Emma has been wonderful. She has been in touch regularly.

    Elise
    Ovarian cancer patient

Cancer Commons is staffed by accomplished researchers with PhDs in the molecular biology and pharmacology of cancer and in Artificial Intelligence. They have joined the Commons to apply their knowledge and expertise to help patients research their options in real time using the latest tools of precision oncology.

Meet the Team
  • Curious Dr. George Logo and Cancer Commons Logo with photo of Cancer Commons Director of Technology Michael Kramer with his late son, Theo.
    NEW Curious Dr. George—Raising AI Right: Prioritizing Humanity in Precision Medicine

    April 8, 2025

    Here’s the latest from our Curious Dr. George! Read “Raising AI Right: Prioritizing Humanity in Precision Medicine” here. Artificial intelligence (AI) holds promise to transform cancer research and treatment. Here, Curious Dr. George asks our very own Director of Technology, Michael Kramer, about the powerful role Cancer Commons can play in shaping the future of AI in oncology. Having lost his son, Theo, to… Read more »

  • Curious Dr. George logo, Cancer Commons logo, photo of DeLeys Brandman, MD, Medical Director, Cancer Commons
    Curious Dr. George—Cancer Commons: Breaking Barriers in Cancer Care

    March 27, 2025

    Here’s the latest from our Curious Dr. George! Read “Cancer Commons: Breaking Barriers in Cancer Care” here. For more than a decade, Cancer Commons has helped patients and their care teams access the information and data they need to make informed decisions. Demand for this kind of help is only growing. Here, Curious Dr. George asks our very own Medical Director, DeLeys Brandman, MD,… Read more »

  • Curious Dr. George logo, Cancer Commons logo, and photo of Jerald P. Radich, MD, MA, MS, Professor, Translational Science & Therapeutics Division, Kurt Enslein Endowed Chair, Fred Hutchinson Cancer Center
    Curious Dr. George—How an Expert Would Manage His Own Chronic Myelogenous Leukemia

    January 9, 2025

    Here’s the latest from our Curious Dr. George! Read “How Would an Expert Manage His Own Chronic Myelogenous Leukemia?” here. When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks expert oncologist Jerald P. Radich MD, MA, MS, how he would handle his own hypothetical case of chronic… Read more »

More News...